Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doruk Erkan

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|June 11, 2021
Expert Perspective: Management of Microvascular and Catastrophic Antiphospholipid SyndromeDoruk Erkan
Current Rheumatology Reports|September 10, 2002
The relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: a review of the literature and management strategiesDoruk Erkan
Women'S Health (London, England)|March 2, 2010
Risk quantification in antiphospholipid syndromeDoruk Erkan
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|January 29, 2024
Antiphospholipid Syndrome: To Classify or Not to Classify?Doruk Erkan
The Journal of Rheumatology|September 9, 2006
Lupus and thrombosisDoruk Erkan
Autoimmunity Reviews|December 2, 2006
Therapeutic and prognostic considerations in catastrophic antiphospholipid syndromeDoruk Erkan
Medicina Clinica|August 22, 2024
Antiphospholipid syndrome: Classification versus diagnosisDoruk Erkan
Current Rheumatology Reports|September 12, 2003
New insights into pregnancy-related complications in systemic lupus erythematosusDoruk Erkan, Lisa Sammaritano
Arthritis and Rheumatism|December 16, 2003
Eligibility of rheumatoid arthritis patients seen in clinical practice for rheumatoid arthritis clinical trials: comment on the article by Sokka and PincusYusuf Yazici, Doruk Erkan
Current Rheumatology Reports|November 25, 2010
Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?Medha Barbhaiya, Doruk Erkan
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
Arthritis & Rheumatology (Hoboken, N.J.)|June 11, 2021
Expert Perspective: Management of Microvascular and Catastrophic Antiphospholipid SyndromeDoruk Erkan
Current Rheumatology Reports|September 10, 2002
The relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: a review of the literature and management strategiesDoruk Erkan
Women'S Health (London, England)|March 2, 2010
Risk quantification in antiphospholipid syndromeDoruk Erkan
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|January 29, 2024
Antiphospholipid Syndrome: To Classify or Not to Classify?Doruk Erkan
The Journal of Rheumatology|September 9, 2006
Lupus and thrombosisDoruk Erkan
Autoimmunity Reviews|December 2, 2006
Therapeutic and prognostic considerations in catastrophic antiphospholipid syndromeDoruk Erkan
Medicina Clinica|August 22, 2024
Antiphospholipid syndrome: Classification versus diagnosisDoruk Erkan
Current Rheumatology Reports|September 12, 2003
New insights into pregnancy-related complications in systemic lupus erythematosusDoruk Erkan, Lisa Sammaritano
Arthritis and Rheumatism|December 16, 2003
Eligibility of rheumatoid arthritis patients seen in clinical practice for rheumatoid arthritis clinical trials: comment on the article by Sokka and PincusYusuf Yazici, Doruk Erkan
Current Rheumatology Reports|November 25, 2010
Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?Medha Barbhaiya, Doruk Erkan
Pageof 20